Empirico is a clinical-stage biotechnology company that combines unmatched expertise in human genetics-driven target discovery with world-class capabilities in siRNA medicines, across a broad range of common diseases with unmet need.
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
| Ownership Private Company |
| Funding $29.5 m |
Empirico is a clinical-stage biotechnology company that utilizes human genetics-driven target discovery and siRNA medicines to develop treatments for common diseases with unmet needs.
Empirico operates as a biotechnology company focusing on human genetics-driven target discovery combined with siRNA drug discovery capabilities.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with Empirico